ClearPoint Neuro, Inc.CLPTNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-59.31%
↑ 16% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-70.57%
Historical baseline
PeriodValueYoY Change
2025-59.31%-4.3%
2024-56.84%+35.1%
2023-87.62%-15.6%
2022-75.80%+3.1%
2021-78.19%-109.5%
2020-37.32%+3.4%
2019-38.64%+44.0%
2018-69.00%+17.6%
2017-83.72%+29.8%
2016-119.21%-